Retrospective cohort study on the safety and efficacy of bevacizumab for metastatic colorectal cancer patients: The HGCSG0801study-Analysis of bevacizumab beyond progression (BBP).

被引：0
|
作者：
Fukushima, Hiraku
Yuki, Satoshi
Kobayashi, Yoshimitsu
Hatanaka, Kazuteru
Kusumi, Takaya
Hosokawa, Ayumu
Miyagishima, Takuto
Takeuchi, Satoshi
Kudo, Mineo
Komatsu, Yoshito
机构：
[1] Tomakomai City Hosp, Dept Gastroenterol, Tomakomai, Japan
[2] Hokkaido Univ, Sch Med, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[3] Hakodate City Hosp, Dept Gastroenterol, Hakodate, Hokkaido, Japan
[4] Keiyukai Sapporo Hosp, Sapporo, Hokkaido, Japan
[5] Toyama Univ, Toyama, Japan
[6] Kushiro Rosai Hosp, Dept Internal Med, Kushiro, Japan
[7] Hokkaido Univ Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan
[8] Sapporo Hokuyu Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[9] Hokkaido Univ Hosp, Dept Canc Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
684
引用
收藏
页数：2
相关论文
共 50 条
  • [21] HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index
    Hatanaka, K.
    Yuki, S.
    Nakano, S.
    Sawada, K.
    Harada, K.
    Okuda, H.
    Ando, T.
    Ogawa, K.
    Furukawa, K.
    Minami, S.
    Saiki, T.
    Ohta, T.
    Kato, T.
    Nakajima, J.
    Sasaki, T.
    Saitoh, S.
    Shindo, Y.
    Tateyama, M.
    Kato, S.
    Nagai, H.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Retrospective cohort study on the safety and efficacy of panitumumab (Pmab) for patients with metastatic colorectal cancer (mCRC): The HGCSG1002 study-Analysis of clinical early predictor for the efficacy
    Sogabe, Susumu
    Fukushima, Hiraku
    Yuki, Satoshi
    Kobayashi, Yoshimitsu
    Miyagishima, Takuto
    Okuda, Hiroyuki
    Kusumi, Takaya
    Doi, Ayako
    Tsuji, Yasushi
    Kawamoto, Yasuyuki
    Ehira, Nobuyuki
    Koike, Masahiko
    Meguro, Takashi
    Takahashi, Yasuo
    Yoshizaki, Koji
    Muto, Shuichi
    Ishiguro, Atsushi
    Kato, Sosuke
    Sakata, Yuh
    Komatsu, Yoshito
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [23] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study
    Li, Rong-Rong
    Zhou, Hui-Jun
    Zeng, De-Yu
    Jiang, Shao-Feng
    Liu, Wu
    Fruehling, Petter
    Liu, Zhen-Yang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 612 - 629
  • [24] CLINICAL OUTCOMES IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS FROM ARIES OBSERVATIONAL COHORT STUDY AND CONFIRMATION OF BRITE DATA ON BEVACIZUMAB BEYOND PROGRESSION
    Cohn, A.
    Bekaii-Saab, T.
    Bendell, J.
    Hurwitz, H.
    Kozloff, M.
    Roach, N.
    Tezcan, H.
    Feng, S.
    Sing, A.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 11 - 11
  • [25] HGCSG1401: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer: Analysis of risk factors for liver dysfunction
    Honda, T.
    Yuki, S.
    Muranaka, T.
    Nakatsumi, H.
    Tsuji, Y.
    Miyagishima, T.
    Yoshida, S.
    Hatanaka, K.
    Sasaki, T.
    Ishiguro, A.
    Muto, O.
    Ohnuma, H.
    Kato, S.
    Sato, A.
    Abe, M.
    Kato, K.
    Onodera, K.
    Eto, K.
    Tateyama, M.
    Amano, T.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index
    Suzuki, K.
    Yuki, S.
    Nakano, S.
    Kawamoto, Y.
    Nakatsumi, H.
    Hatanaka, K.
    Ando, T.
    Furukawa, K.
    Ishiguro, A.
    Ohta, T.
    Eto, K.
    Nakajima, J.
    Nakamura, M.
    Sogabe, S.
    Kato, K.
    Tateyama, M.
    Kato, S.
    Sekiguchi, M.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [27] A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer (HGCSG1503): Analysis of tumor location
    Ogawa, Kohei
    Yuki, Satoshi
    Kawamoto, Yasuyuki
    Yagisawa, Masataka
    Harada, Kazuaki
    Okuda, Hiroyuki
    Furukawa, Kouichi
    Honda, Takuya
    Dazai, Masayoshi
    Kato, Takashi
    Sasaki, Takahide
    Shindo, Yoshiaki
    Ota, Sakae
    Sato, Atsushi
    Ueda, Akira
    Kato, Sosuke
    Fukunaga, Akira
    Nagai, Hikari
    Sakata, Yuh
    Komatsu, Yoshito
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [28] HGCSG1401: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer: Analysis of risk factors for liver dysfunction
    Ishiguro, A.
    Yuki, S.
    Nakano, S.
    Kawamoto, Y.
    Sawada, K.
    Tsuji, Y.
    Honda, T.
    Miyagishima, T.
    Yoshida, S.
    Hatanaka, K.
    Sasaki, T.
    Muto, O.
    Ohnuma, H.
    Kato, S.
    Sato, A.
    Abe, M.
    Kato, K.
    Amano, T.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 36 - 36
  • [29] The efficacy and safety of irinotecan± bevacizumab compared with oxaliplatin± bevacizumab for metastatic colorectal cancer A meta-analysis
    Dai, Jiali
    Chen, Yuetong
    Gong, Yang
    Wei, Jingsun
    Cui, Xiaowen
    Yu, Hualin
    Zhao, Wenjing
    Gu, Dongying
    Chen, Jinfei
    MEDICINE, 2019, 98 (39)
  • [30] EFFICACY AND SAFETY OF BEVACIZUMAB-CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER
    Bensalem, A.
    Ayadi, L.
    Benlakhlef, L.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 114 - 114
12345